Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Public ClinicalTrials.gov record NCT04748601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Study identification
- NCT ID
- NCT04748601
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 19, 2021 (Actual)
- Primary completion
- Sep 2026 (Estimated)
- Completion
- Sep 2026 (Estimated)
- Last update posted
- Jan 27, 2025
2021 – 2026
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Upsher-Smith Clinical Trial Site #5 | Birmingham | Alabama | 35205 | Withdrawn |
| Upsher-Smith Clinical Trial Site #15 | La Jolla | California | 92093 | Recruiting |
| Upsher-Smith Clinical Trials Site #3 | Aurora | Colorado | 80045 | Withdrawn |
| Upsher-Smith Clinical Trial Site #1 | Stamford | Connecticut | 06901 | Completed |
| Upsher-Smith Clinical Trial Site #12 | Loxahatchee Groves | Florida | 33470 | Withdrawn |
| Upsher-Smith Clinical Trial Site #8 | Orlando | Florida | 32789 | Withdrawn |
| Upsher-Smith Clinical Trial Site #14 | Tampa | Florida | 33620 | Recruiting |
| Upsher-Smith Clinical Trial Site #2 | Ann Arbor | Michigan | 48104 | Withdrawn |
| Upsher-Smith Clinical Trial Site #11 | Jackson | Mississippi | 39216 | Withdrawn |
| Upsher-Smith Clinical Trial Site #10 | Bridgeton | Missouri | 63044 | Withdrawn |
| Upsher-Smith Clinical Trial Site #4 | Cincinnati | Ohio | 45229 | Recruiting |
| Upsher-Smith Clinical Trial Site #6 | Portland | Oregon | 97239 | Recruiting |
| Upsher-Smith Clinical Trials Site #7 | Springfield | Oregon | 97477 | Recruiting |
| Upsher-Smith Clinical Trial Site #13 | McAllen | Texas | 78503 | Withdrawn |
| Upsher-Smith Clinical Trial Site #9 | Huntington | West Virginia | 25701 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04748601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2025 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04748601 live on ClinicalTrials.gov.